INTRODUCTION {#s1}
============

In 2006, the National Council on Radiation Protection and Measurements (NCRP) published a report titled \[[@R1]\] 'Ionizing Radiation Exposure of the Population of the United States'. The report showed that human-made radiation contributes 50% of the radiation in our environment. Of this human-made radiation, 36% comes from diagnostic radiation, including 5% from general X-rays and fluoroscopy, 24% from computed tomography (CT), and 7% from interventional radiology. It is clear that the biggest amount of radiation received by the population comes from general diagnostic radiation. Nonetheless, interventional radiology, though contributing a lesser extent of radiation delivery to the population, can emit very high individual doses that can possibly reach the deterministic threshold.

Currently, interventional radiology procedures are increasingly performed in a number of pathological conditions. However, the high radiation dose from lengthy procedures can harm patients. Physicians are concerned about serious radiation-induced injury caused by high radiation skin dose or lengthy exposure to fluoroscopy in some procedures. In light of such concerns, the World Health Organization (WHO) and the German Institute for Radiation Hygiene (ISH) \[[@R2]\] organised a workshop on ensuring efficacy and radiation safety in interventional radiology. The Food and Drug Administration (FDA) published documents \[[@R3]\] on avoiding deterministic effects in cardiology procedures. The absorbed dose in the patient's skin of 2 Gray (Gy) should raise concerns about the onset of transient erythema and 3 Gy for temporary epilation. \[[@R3]\] Information about the absorbed dose to skin should be included in the patient's records.

A number of investigators have utilised the air kerma area product values to assess radiation risk from fluoroscopic studies \[[@R4]--[@R9]\]. The air kerma area product is a better indicator of risk, compared to the entrance skin dose, due to the fact that air kerma area product is a product of entrance skin dose and field size \[[@R10]\]. This study was carried out to assess the radiation dose to patients undergoing interventional radiology procedures at Ramathibodi Hospital, Bangkok, Thailand.

MATERIALS AND METHODS {#s2}
=====================

X-ray system {#s2a}
------------

The evaluation of patient dose was carried out at the radiology department of Ramathibodi Hospital. The interventional procedures were performed using two radiographic systems. The transarterial oily-chemoembolisation and femoral angiography procedures were performed using the Toshiba Infinix VC-I FPD with X-ray generator model XTP 8100G (single-plane x-ray system), whereas diagnostic cerebral angiography and therapeutic cerebral angiography (brain arteriovenous malformations and duralarteriovenous fistula embolization) were performed using Toshiba Infinix VB-I with X-ray generator model XTP 8100G (bi-plane x-ray system). The exposure parameters, such as tube potential and tube current, were controlled by automatic brightness control (ABC). The radiographic systems utilised 4 field diameters including 6 inches, 8 inches, 12 inches, and 16 inches for Infinix VC-I FPD; and 5 inches, 7 inches, 9 inches and 12 inches for Infinix VB-I. All X-ray tubes were equipped with built-in air kerma area product meter (Diamentor K1S) at the collimator exit with capability to display the cumulative air kerma area product for fluoroscopic and radiographic examinations. The half-value-layer (HLV), tested at tube potential of 80 kVp and 74 kVp prior to the air kerma area product calibration, were 4.0 mmAl and 3.7 mmAl for Infinix VC-I FPD and Infinix VB-I, respectively.

Air Kerma Area Product meter calibration {#s2b}
----------------------------------------

Built-in air kerma area product meter was calibrated *in situ* with a calibrated ionisation chamber (Accu-Pro^TM^). In this calibration procedure, a Fuji image photo-stimulable phosphor plate was exposed and read by a Fuji FCR 5000 pulse for beam area determination. The calibration procedures and beam area determination were recommended by the International Atomic Energy Agency (IAEA TRS 457) \[[@R10]\]. The calibration coefficient of air kerma area product meter (N~KAP~) at tube voltage between 50 kV and 100 kV was found to vary within ± 5.07%, ± 7.20%, ± 4.86% from calibration coefficient of 80 kV for Infinix VC-I FPD, Infinix VB-I tube 1 and tube 2 respectively.

Patient data collection {#s2c}
-----------------------

A total of 120 patients (78 male, 42 female, mean age of 51.29 ± 16.88 and 53.43 ± 20.94 years for male and female, respectively) who underwent interventional radiology procedures participated in this study and signed a consent form. Ethical clearance was obtained from the Ramathibodi Hospital research ethics committee. Patient-specific data, i.e., couch position, field of view (FOV), kerma area product, and tube potential were collected from the displayed monitor for purpose of dose calculation.

Air kerma area product was corrected with calibration coefficient of air kerma area product meter for average tube potential of each projection. Entrance skin dose (ESD) was calculated from air kerma area product ($\text{M}_{\text{Q}}^{\text{KAF}}$ ), beam area (A~nam~) and calibration coefficient of air kerma area product meter ($\text{N}_{\text{P}_{\text{XA}}\text{Q}}$ ) at calibrated distance (see equation of entrance dose below) to focal-to-skin distance (FSD) by inverse square law and multiplied by backscatter factor for each series. Backscatter factor was interpolated from the tabulated data by using half value layer, and the focal-to-skin distance was calculated from the couch position.
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RESULTS AND DISCUSSION {#s3}
======================

Table 1 shows the mean, median and standard deviation values of the kVp, mA, ms, and field of view (FOV). The mean values of tube potential for transarterial oily-chemoembolisation, femoral angiography, diagnostic cerebral angiography, therapeutic cerebral angiography are 82.9, 80.3, 76 (frontal), 74 (lateral), 75.6 (frontal) and 74.6 (lateral) kVp, respectively. The mean, median,maximum and standard deviation values of air kerma area product (KAP), entrance skin dose (ESD), number of images and fluoroscopy time are shown in Table 2 and 3.

###### 

The mean, the median and the standard deviation values of the kVp, mA, ms, Field of View (FOV).

                                     **kVp**   **mA**   **ms**   **FOV**                                                    
  ---------------------------------- --------- -------- -------- --------- ----- -------- ------ ------ ------- ------ ---- ------
  TOCE                               82.9      82       5.03     124.2     125   25.67    69.1   74.9   18.43   13.4   12   2.59
  Femoral angiography                80.3      80       1.91     79.9      80    43.55    21.8   10     21.99   15.9   16   0.49
  Diagnostic cerebral angiography                                                                                           
  Frontal                            76        74       3.75     259.3     160   156.44   54.7   63     23.32   9      9    1.21
  Lateral                            74        74       0.00     399.4     400   7.18     41.3   40     10.65   10     9    1.59
  Therapeutic cerebral angiography                                                                                          
  Frontal                            75.6      74       2.57     217.3     160   110.48   63.6   66     16.44   7.7    9    2.06
  Lateral                            74.6      74       2.38     380.8     400   70.55    46.3   43     18.23   8.7    9    2.58

###### 

The mean, the median and the standard deviation values of air kerma-area product (KAP), Entrance dose (ED), Number of images and Fluoroscopy time.

                                     **No.**   **KAP (cGy-cm^2^)**   **ED (mGy)**   **Number of images**   **Fluoroscopy time (min)**                                                               
  ---------------------------------- --------- --------------------- -------------- ---------------------- ---------------------------- -------- -------- -------- ------- -------- ------- ------- -------
  TOCE                               30        9099.41               7719.30        5288.79                394.86                       339.55   292.28   104.83   97.5    45.71    14.94   8.8     12.87
  Femoral angiography                30        3101.87               2355.93        1791.89                100.36                       78.21    59.65    220.73   195.5   71.00    5.9     4.95    4.11
  Diagnostic cerebral angiography                                                                                                                                                                   
  Frontal                            30        3310.97               2724.04        2398.89                400.40                       308.65   318.48   378.23   284.5   287.26   13.27   12.25   7.25
  Lateral                                      3500.68               3328.83        1909.86                154.77                       125.96   93.56    118.13   110.5   37.24                    
  Therapeutic cerebral angiography                                                                                                                                                                  
  Frontal                            30        5014.75               3706.52        4476.37                876.52                       718.48   773.43   354.06   295.5   224.42   40.1    32.8    27.84
  Lateral                                      9731.47               9404.30        4411.78                591.93                       606.57   312.42   334.73   317.5   177.97                   

\*n = 33, percentages in parentheses.

###### 

Mean Fluoroscopy, KAP and ED of this study and other study.

  **Procedure**                                **Study**                                    **Mean Fluoroscopy time (min)**   **Mean KAP (Gy-cm^2^)**   **Mean ED (mGy)**
  ---------------------------------- --------- -------------------------------------------- --------------------------------- ------------------------- -------------------
  TOCE                                         This study                                   14.94                             90.99                     394.86
                                               Wongsanon S., et al. \[[@R12]\]              8.58                              121.09                    370
                                               Donald L., et al.\[[@R13]\]                  16.8                              282.32                    1,406
                                               Vano et al. \[[@R14]\]                       \-                                81.7                      500
  Femoral angiography                          This study                                   5.9                               31.02                     100.36
                                               Vano et al. \[[@R14]\]                       \-                                66.6                      \-
                                               Ioaninis A. Tsalafoutas, et al. \[[@R15]\]   2.6                               68                        257
                                               McParland \[[@R16]\]                         7.2                               46.7                      \-
  Diagnostic cerebral angiography    Frontal   This study                                   13.27                             33.11                     400.40
  Lateral                            35.01     154.77                                                                                                   
                                               Ioaninis A. Tsalafoutas, et al. \[[@R15]\]   4.3                               50                        349
                                               McParland \[[@R16]\]                         12.1                              74.1                      220
                                               Marshall, et al. \[[@R16]\]                  \-                                48.5                      150
  Therapeutic cerebral angiography   Frontal   This study                                   40.1                              50.15                     876.52
  Lateral                            97.31     591.93                                                                                                   
                                               Donald L., et al.\[[@R13]\]                  92.5                              339.76                    3791
                                               McParland \[[@R16]\]                         34.1                              105                       \-
                                               Marshall, et al. \[[@R16]\]                  \-                                122                       \-

In this study, the highest entrance dose, number of images and fluoroscopy time of 362.63 cGy, 1015 images and 126 minutes, respectively, were found in the lateral tube position of therapeutic cerebral angiography. However, the highest air kerma area product was from transarterial oily-chemoembolisation with a value of 264.37 Gy-cm^2^. There were two patients who received entrance doses higher than 3 Gy in a frontal view of therapeutic cerebral angiography. This dose level is higher than a threshold dose for temporary epilation.

From the results, wide variations (9.89--230.00 Gy-cm^2^ and 15.47--362.63 cGy in therapeutic cerebral angiography) were found in air kerma area product and entrance skin dose. Complicated procedures require more operating time and deliver higher radiation doses to patients, compared to common and non-complicated procedures. Differences in the irradiated field size can also cause the difference in radiation dose to patients. In this study, it was found that larger irradiated fields such as transarterial oily-chemoembolisation produced higher air kerma area product than the smaller field in therapeutic cerebral angiography. However, the entrance skin dose from transarterial oily-chemoembolisation was smaller, as it required less irradiation time. Table 4 shows the comparison between air kerma area product and entrance skin dose from this study with other published data. The mean air kerma area product of this study was lower than other studies in transarterial oily-chemoembolisation and femoral angiography except when compared with Veno's study in transarterial oily-chemoembolisation. In diagnostic and therapeutic cerebral angiography procedures, the mean air kerma area product was lower than in other studies, when compared with each tube. But it was higher than that of some studies when compared with both tubes.

To utilise the displayed air kerma area product values from the console screen, with proper calibration values, conversion of air kerma area product to entrance skin dose can be carried out and used. In this study, to set up a concerned level for deterministic risk of 2 Gy, correlations (R^2^) between the air kerma area product values and the calculated entrance skin dose of 0.83, 0.98, 0.86, 0.77, 0.92, 0.69 for transarterial oily-chemoembolisation, femoral angiography, diagnostic cerebral angiography frontal and lateral, therapeutic cerebral angiography frontal and lateral, respectively, were found. The corresponding air kerma area product values were 410.77, 606.66, 162.73, 464.11, 118.12 and 335.21 Gy-cm^2^.

CONCLUSION {#s4}
==========

High-dose radiological procedures such as interventional radiology have been known to expose patients to high doses of radiation. The high dose levels can sometimes reach the deterministic risk threshold. Air kerma area product meters are now commonly incorporated with the fluoroscopic unit to provide feedback on radiation dose emitted from the x-rays tube. The air kerma area product meter calibrated using proper *in situ* protocol can be used as a monitoring tool to alert clinicians regarding deterministic risk of radiation such as early transient erythema or epilation.
